SEPREVEN: a Stepped-wedge Randomised Controlled Trial (SEPREVEN)
Study on Preventing Adverse Events in Neonates (SEPREVEN): a Stepped-wedge Randomised Controlled Trial to Reduce Adverse Event Rates in the NICU
Sponsor: Dr Caeymaex Laurence
This NA trial investigates Catheter-related Bloodstream Infection (CRBSI) Nos and Extravasation Injury and is currently completed. Dr Caeymaex Laurence leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 3 earlier versions
-
Feb 2020 — Jun 2020 [monthly]
Recruiting NA
-
Jun 2018 — Feb 2020 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Nov 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Dr Caeymaex Laurence
- Ministry of Health, France
- Paris 12 Val de Marne University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Angers, France , Caen, France , Créteil, France , Grenoble, France , Le Kremlin-Bicêtre, France , Lille, France , Nice, France , Paris, France , Poissy, France , Pontoise, France and 2 more locations